Cafepharma Today

April 21 2025 - Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
FDA moves to block biopharma employees from serving on advisory committees
A big moment is coming for psychedelics
How a scrapped Pfizer drug became a winner for SpringWorks
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
BioPharma Dive
Monday, April 21, 2025 - 11:13am
tags:
Sanofi, Regeneron, Dupixent, FDA, chronic hives
AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer
Fierce Pharma
Monday, April 21, 2025 - 11:12am
tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer, clinical trials
Trodelvy-Keytruda combo improves cancer trial outcomes
Investing.com
Monday, April 21, 2025 - 11:11am
tags:
Gilead Sciences, Trodelvy, Keytruda, Merck, metastatic triple-negative breast cancer
FDA rejection of extended dosing interval is another piece of bad news for Regeneron’s Eylea HD
Fierce Pharma
Monday, April 21, 2025 - 10:22am
tags:
FDA, Regeneron, Eylea, CRL
FDA moves to block biopharma employees from serving on advisory committees
Fierce Pharma
Monday, April 21, 2025 - 10:11am
tags:
FDA, advisory committees, Marty Makary, regulatory
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
Stock Titan
Monday, April 21, 2025 - 10:09am
tags:
Immunovant, IMVT-1402, Eric Venker
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
Fierce Biotech
Monday, April 21, 2025 - 10:04am
tags:
VelaVigo Bio, Olin Biosciences, bispecific antibodies
FDA cuts outlined in draft HHS budget
BioPharma Dive
Monday, April 21, 2025 - 10:02am
tags:
FDA, layoffs, HHS
A big moment is coming for psychedelics
Pharma Voice
Monday, April 21, 2025 - 10:01am
tags:
COMPASS Pathways, clinical trials, psilocybin, COMP360, clinical depression
How a scrapped Pfizer drug became a winner for SpringWorks
Pharma Voice
Monday, April 21, 2025 - 10:00am
tags:
SpringWorks Therapeutics, Pfizer, neurofibromatosis, mirdametinib, FDA
Merida raises $121m for Graves drug, and other financings
Pharmaphorum
Monday, April 21, 2025 - 9:57am
tags:
Merida Biosciences, funding, Graves' disease
Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts
Fierce Pharma
Thursday, April 17, 2025 - 11:06pm
tags:
diabetes, obesity, Eli Lilly, Novo Nordisk, BMO Capital Markets
GSK kicks off Blenrep's market return with first myeloma combo nod in UK
Fierce Pharma
Thursday, April 17, 2025 - 11:04pm
tags:
GSK, Blenrep, UK, Multiple Myeloma
Stem cells to treat Parkinson's? 2 small studies hint at success
NPR
Thursday, April 17, 2025 - 10:54pm
tags:
Parkinson's Disease, stem cells, BlueRock Therapeutics, Bayer, clinical trials
Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s
Yahoo/Bloomberg
Thursday, April 17, 2025 - 11:34am
tags:
Eli Lilly, clinical trials, obesity, orforglipron, Ozempic
J&J’s electrophysiology sales dip amid slow Varipulse start
Medtech Dive
Thursday, April 17, 2025 - 11:32am
tags:
JNJ, Medtech, PFA, Medtronic, Boston Scientific, earnings, Varipulse
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics
Yahoo Finance
Thursday, April 17, 2025 - 11:28am
tags:
BigHat Biosciences, Eli Lilly, drug discovery, artificial intelligence, machine learning
CDC panel backs broader use of RSV shots
BioPharma Dive
Thursday, April 17, 2025 - 11:25am
tags:
CDC, ACIP, vaccines, RSV, GSK, Pfizer, Moderna Therapeutics
Mark Cuban’s drug firm targets injectable shortages
Beckers Hospital Review
Thursday, April 17, 2025 - 11:23am
tags:
Mark Cuban, Cost Plus Drugs, Morris & Dickson, injectables
Novartis scores NFL deal to tackle health outcomes
Pharma Voice
Thursday, April 17, 2025 - 11:22am
tags:
Novartis, pharma marketing, NFL

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

You Can Probably Smell That Planet From Here
In the Pipeline
Proton Pump Inhibitors Do More Than You Think
In the Pipeline
Entropy, Enthalpy, and Hydrophobicity
In the Pipeline
The Continuing Crisis, Part XII: Behold RFK Jr.'s FDA
In the Pipeline
RNA Motifs Coming Into Focus
In the Pipeline
Pharmaceutical Tariffs: The What and the How
In the Pipeline
Metallic Flatland
In the Pipeline
The Continuing Crisis, Part XI: Feral Children, Breaking Things
In the Pipeline
Methyl Groups Will Always Be Magic
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.